Amylyx Pharmaceuticals In... (AMLX)
3.47
0.02 (0.58%)
At close: Jan 29, 2025, 3:59 PM
3.50
0.86%
After-hours Jan 29, 2025, 07:58 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | 20.09 | -12.39 | -11.9 | -22.76 | -68.87 |
| PS Ratio | 2.60 | 110.55 | 3.67K | 1.57K | 715.53 |
| PB Ratio | 2.28 | 7.22 | -6.92 | -15.29 | -40.24 |
| P/FCF Ratio | 92.69 | -13.47 | -13.91 | -27.69 | -95.47 |
| P/OCF Ratio | 83.03 | -13.66 | -13.98 | -27.8 | -95.47 |
| OCF/S Ratio | 0.03 | -8.09 | -262.45 | -56.46 | -7.49 |
| Debt / Equity Ratio | 0.01 | 0.02 | n/a | -0.02 | -0.59 |
| Quick Ratio | 5.20 | 7.99 | 5.84 | 1.86 | 0.71 |
| Current Ratio | 5.66 | 8.20 | 5.84 | 1.86 | 0.71 |
| Asset Turnover | 0.74 | 0.06 | 0.00 | 0.05 | 0.44 |
| Interest Coverage | n/a | -46.92 | n/a | -17.05 | -10.62 |
| Return on Equity (ROE) | 0.11 | -0.58 | 0.58 | 0.67 | 0.58 |
| Return on Assets (ROA) | 0.10 | -0.51 | -0.83 | -3.18 | -4.6 |
| Return on Capital (ROIC) | 0.09 | -0.58 | -0.94 | -5.75 | 10.35 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 93.32% | 86.54% | 81.75% | -3.68K% | -734.43% |
| Net Profit Margin | 12.94% | -892.38% | -30.83K% | -6.90K% | -1.04K% |
| Pretax Profit Margin | 14.26% | -888.89% | -30.85K% | -6.50K% | -961.85% |
| Operating Profit Margin | 10.19% | -905.72% | -29.01K% | -6.00K% | -950.49% |
| FCF Margin | 2.80% | -820.5% | -26.37K% | -5.67K% | -749.44% |
| EBITDA Margin | 10.48% | -903.53% | -29.00K% | -6.00K% | 78.12% |